Pulmonary

Solutions to make RNA therapies safer
Modifications to lipid nanoparticles blocks inflammation and reduces damage.
August 29, 2025
Getty Images 2151198847
Cystic fibrosis patients at risk of persistent lung infection
Despite new drugs called modulators, research shows bacterial infections remain hard to clear.
August 28, 2025
Air trapping (colored pink) in lungs of a cystic fibrosis patient before CFTR modulator treatment.
Computerized decision support benefits children on ventilators for lung failure
Patients experienced less time spent on mechanical support and improved recovery.
August 22, 2025
Getty Images 2153665059
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Brinsupri becomes first FDA-approved therapy for NCFB
The important decision was made following positive results from the ASPEN and WILLOW trials.
August 21, 2025
Getty Images 2184939212
Overlooked protein could alter outcome of lung disease
Epac1 has potential as a new drug target for idiopathic pulmonary fibrosis.
August 8, 2025
AM-001 blocks a key protein (Epac1), which helps protect another protein (FoxO3a) from being broken down. It also shuts down several harmful signals that drive lung scarring in idiopathic pulmonary fibrosis, helping to reduce lung damage.
How lymphatic vessels help heal by switching gears
The protein PAR1 triggers a process that clears inflammation and repairs lung damage.
August 7, 2025
Lymphatic vessels (green) are wrapped around blood vessels (red) in a mouse lung. The PAR1 protein triggers lymphatic vessels to be permeable, so they can absorb more fluid and immune cells for healing—a response distinct from blood vessels, where similar changes result in leakage and disease.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
CHEST publishes new guideline on NSCLC management
The evidence-based recommendations will help establish standard of care treatment for patients with early-stage disease.
August 6, 2025
Getty Images 2204506575
Eliminating race from lung function assessments
Physicians, researchers push to update AMA guidelines to improve pulmonary impairment testing process.
August 4, 2025
Getty Images 1420686338
Researchers create 3D-printed living lung tissue
The revolutionary model opens the door to improved understanding of lung disease.
July 29, 2025
Dr. Emmanuel Osei has developed a way to 3D print tissue that resembles a living lung. This work could change how lung disease is studied and improve health options for those living with the illness.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Long COVID’s lasting health concerns
Abnormal PET/MRI findings indicate potential pulmonary and cardiac issues.
July 29, 2025
Getty Images 1392283024
Bronchoscopy performance in diagnostic accuracy, yield
Robotic and electromagnetic navigation bronchoscopy demonstrate similar results to CT-guided biopsy with fewer complications.
July 24, 2025
Getty Images 1500448026
Lung cancer treatment and corticosteroids may not mix
The common medication was found to limit effectiveness of immunotherapies by interfering with T-cell production.
July 22, 2025
Getty Images 1293133630
Page 1 of 20
Next Page
Most Popular
GINA releases 2025 asthma guidelines update
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Concerns mount over Singulair
Zinc’s emerging role in pediatric asthma, allergic rhinitis
Researchers create 3D-printed living lung tissue